Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1925)
IDEXX LABORATORIES INC /DE (IDXX)
Kingsley Lawrence D — Director
Shares
2,203
Price
$532.08
Total Value
$1.17M
Shares Held After
9,568
% of Holdings
18.7%
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Phipps Chad F — Senior Vice President, Chief Legal&Corporate Affairs Officer and Secretary
Shares
3,000
Price
$98.35
Total Value
$295.05K
Shares Held After
65,231
% of Holdings
4.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
1,590
Price
$90.00
Total Value
$143.10K
Shares Held After
1,590
% of Holdings
50.0%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
1,590
Price
$85.00
Total Value
$135.15K
Shares Held After
3,180
% of Holdings
33.3%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
5,386
Price
$90.00
Total Value
$484.74K
Shares Held After
2,547
% of Holdings
67.9%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
5,387
Price
$85.00
Total Value
$457.89K
Shares Held After
7,933
% of Holdings
40.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
4,564
Price
$85.00
Total Value
$387.94K
Shares Held After
78,532
% of Holdings
5.5%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
2,900
Price
$91.27
Total Value
$264.68K
Shares Held After
827,991
% of Holdings
0.3%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
7,100
Price
$90.27
Total Value
$640.92K
Shares Held After
830,891
% of Holdings
0.8%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
18
Price
$79.96
Total Value
$1.44K
Shares Held After
13,427
% of Holdings
0.1%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
759
Price
$79.96
Total Value
$60.69K
Shares Held After
312,230
% of Holdings
0.2%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
912
Price
$79.96
Total Value
$72.92K
Shares Held After
318,866
% of Holdings
0.3%
Bionano Genomics, Inc. (BNGO)
Luderer Albert — Director
Shares
4,000
Price
$1.21
Total Value
$4.84K
Shares Held After
8,000
% of Holdings
50.0%
NewAmsterdam Pharma Co N.V. (NAMS)
Smither John W — Director
Shares
1,600
Price
$25.32
Total Value
$40.51K
Shares Held After
8,760
% of Holdings
15.4%
AGILENT TECHNOLOGIES, INC. (A)
Dolsten Mikael — Director
Shares
634
Price
$151.38
Total Value
$95.97K
Shares Held After
4,924
% of Holdings
11.4%
Cytosorbents Corp (CTSO)
Chan Phillip P. — Director
Shares
200,000
Price
$0.35
Total Value
$70.00K
Shares Held After
1,944,432
% of Holdings
10.3%
Embecta Corp. (EMBC)
Morris Milton Mayo — Director
Shares
6,293
Price
$5.88
Total Value
$36.97K
Shares Held After
53,828
% of Holdings
10.5%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
900
Price
$24.35
Total Value
$21.91K
Shares Held After
153,082
% of Holdings
0.6%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
3,745
Price
$24.35
Total Value
$91.19K
Shares Held After
163,854
% of Holdings
2.2%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
9,705
Price
$26.22
Total Value
$254.50K
Shares Held After
0
% of Holdings
100.0%
REPLIGEN CORP (RGEN)
Loeillot Olivier — Director
Shares
3,035
Price
$165.90
Total Value
$503.51K
Shares Held After
48,369
% of Holdings
5.9%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
31,500
Price
$103.52
Total Value
$3.26M
Shares Held After
781,709
% of Holdings
3.9%
Perspective Therapeutics, Inc. (CATX)
Lantheus Alpha Therapy, LLC — 10% Owner
Shares
167,149
Price
$3.15
Total Value
$526.05K
Shares Held After
11,273,364
% of Holdings
1.5%
LivaNova PLC (LIVN)
Story Brooke — Director
Shares
2,300
Price
$81.42
Total Value
$187.27K
Shares Held After
7,488
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$491.69
Total Value
$157.34K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$490.94
Total Value
$569.48K
Shares Held After
324,763
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,514
Price
$490.01
Total Value
$741.87K
Shares Held After
325,923
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,425
Price
$489.12
Total Value
$1.68M
Shares Held After
327,437
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,818
Price
$488.08
Total Value
$1.38M
Shares Held After
330,862
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
223
Price
$486.88
Total Value
$108.57K
Shares Held After
333,680
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$485.85
Total Value
$19.43K
Shares Held After
333,903
% of Holdings
0.0%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
18,378
Price
$3.67
Total Value
$67.45K
Shares Held After
11,242,531
% of Holdings
0.2%
Tenon Medical, Inc. (TNON)
HRT FINANCIAL LP — 10% Owner
Shares
1,506
Price
$3.70
Total Value
$5.57K
Shares Held After
1,946
% of Holdings
43.6%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
1,175
Price
$43.71
Total Value
$51.36K
Shares Held After
166,025
% of Holdings
0.7%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
2,477
Price
$42.81
Total Value
$106.03K
Shares Held After
167,200
% of Holdings
1.5%
VERACYTE, INC. (VCYT)
McGuire Annie — EVP, General Counsel
Shares
1,100
Price
$43.67
Total Value
$48.04K
Shares Held After
131,160
% of Holdings
0.8%
VERACYTE, INC. (VCYT)
McGuire Annie — EVP, General Counsel
Shares
2,154
Price
$42.79
Total Value
$92.17K
Shares Held After
132,260
% of Holdings
1.6%
VERACYTE, INC. (VCYT)
Febbo Phillip G. — Chief Scientific&Med Officer
Shares
2,705
Price
$43.66
Total Value
$118.11K
Shares Held After
133,048
% of Holdings
2.0%
VERACYTE, INC. (VCYT)
Febbo Phillip G. — Chief Scientific&Med Officer
Shares
10,405
Price
$42.89
Total Value
$446.30K
Shares Held After
135,753
% of Holdings
7.1%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
11,351
Price
$219.18
Total Value
$2.49M
Shares Held After
770,350
% of Holdings
1.5%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
100,650
Price
$218.39
Total Value
$21.98M
Shares Held After
781,701
% of Holdings
11.4%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
7,500
Price
$217.28
Total Value
$1.63M
Shares Held After
882,351
% of Holdings
0.8%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
399
Price
$366.56
Total Value
$146.26K
Shares Held After
1,302,145
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
826
Price
$365.41
Total Value
$301.83K
Shares Held After
1,302,544
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,329
Price
$364.48
Total Value
$484.39K
Shares Held After
1,303,370
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
565
Price
$363.34
Total Value
$205.29K
Shares Held After
1,304,699
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,992
Price
$362.65
Total Value
$722.40K
Shares Held After
1,305,264
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,242
Price
$361.61
Total Value
$449.12K
Shares Held After
1,307,256
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,320
Price
$360.47
Total Value
$836.28K
Shares Held After
1,308,498
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,392
Price
$359.39
Total Value
$1.22M
Shares Held After
1,310,818
% of Holdings
0.3%
Showing 351–400 of 1925 transactions (page 8 of 39)